Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma
CK Tsai, CM Yeh, TL Hsu, CJ Li, C Tin, LT Hsiao… - Supportive Care in …, 2021 - Springer
Purpose Multiple myeloma (MM), a clonal plasma cell malignancy, composes around 10%
of hematologic malignancies. Though recent advances in treatment have dramatically …
of hematologic malignancies. Though recent advances in treatment have dramatically …
Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma
T Chun-Kuang, Y Chiu-Mei, H Te-Lin… - Supportive Care in …, 2021 - search.proquest.com
Purpose Multiple myeloma (MM), a clonal plasma cell malignancy, composes around 10%
of hematologic malignancies. Though recent advances in treatment have dramatically …
of hematologic malignancies. Though recent advances in treatment have dramatically …
Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma
CK Tsai, CM Yeh, TL Hsu, CJ Li… - Supportive care in …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose Multiple myeloma (MM), a clonal plasma cell malignancy, composes around 10%
of hematologic malignancies. Though recent advances in treatment have dramatically …
of hematologic malignancies. Though recent advances in treatment have dramatically …
Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma.
CK Tsai, CM Yeh, TL Hsu, CJ Li, C Tin… - Supportive Care in …, 2021 - europepmc.org
Purpose Multiple myeloma (MM), a clonal plasma cell malignancy, composes around 10%
of hematologic malignancies. Though recent advances in treatment have dramatically …
of hematologic malignancies. Though recent advances in treatment have dramatically …
Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma.
CK Tsai, CM Yeh, TL Hsu, CJ Li, C Tin… - Supportive Care in …, 2021 - search.ebscohost.com
Abstract Purpose: Multiple myeloma (MM), a clonal plasma cell malignancy, composes
around 10% of hematologic malignancies. Though recent advances in treatment have …
around 10% of hematologic malignancies. Though recent advances in treatment have …
Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma.
CK Tsai, CM Yeh, TL Hsu, CJ Li, C Tin… - Supportive Care in …, 2021 - go.gale.com
Purpose Multiple myeloma (MM), a clonal plasma cell malignancy, composes around 10%
of hematologic malignancies. Though recent advances in treatment have dramatically …
of hematologic malignancies. Though recent advances in treatment have dramatically …
Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma.
CK Tsai, CM Yeh, TL Hsu, CJ Li, C Tin, LT Hsiao… - 2021 - cabidigitallibrary.org
Abstract Purpose: Multiple myeloma (MM), a clonal plasma cell malignancy, composes
around 10% of hematologic malignancies. Though recent advances in treatment have …
around 10% of hematologic malignancies. Though recent advances in treatment have …
Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma
CK Tsai, CM Yeh, CJ Li, C Tin, LT Hsiao… - Supportive Care in …, 2021 - scholar.nycu.edu.tw
Purpose: Multiple myeloma (MM), a clonal plasma cell malignancy, composes around 10%
of hematologic malignancies. Though recent advances in treatment have dramatically …
of hematologic malignancies. Though recent advances in treatment have dramatically …